Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Surgical Retina and Vitreous, 2016 - 2018
- University of Michigan Health SystemResidency, Ophthalmology, 2013 - 2016
- Mayo Clinic College of MedicineClass of 2012
- Grove City CollegeB.S., Molecular Biology, Magna cum Laude, 2003 - 2006
- University of MiamiNo degree, 2002
Certifications & Licensure
- MI State Medical License 2013 - 2027
- CA State Medical License 2016 - 2026
- FL State Medical License 2021 - 2025
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- The George Slocum Resident Research Award – 1st Place University of Michigan, 2015
- Walter R. Parker Resident Teaching Award – 3rd Place University of Michigan, 2015
- Aizman Award University of Michigan, 2016
- Join now to see all
Publications & Presentations
PubMed
- 30 citationsCombined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seedsStephen J. Smith, Jose S. Pulido, Diva R. Salomao, Brian D. Smith, Brian G. Mohney
The British Journal of Ophthalmology. 2012-08-01 - 62 citationsEvaluating the risk of extraocular tumour spread following intravitreal injection therapy for retinoblastoma: a systematic reviewStephen J. Smith, Brian D. Smith
The British Journal of Ophthalmology. 2013-10-01 - 639 citationsGabapentin Receptor α2δ-1 Is a Neuronal Thrombospondin Receptor Responsible for Excitatory CNS SynaptogenesisCagla Eroglu, Nicola J. Allen, Michael W. Susman, Nancy A. O'Rourke, Chan Young Park
Cell. 2009-10-16
Journal Articles
- Preclinical acute ocular safety study of combined intravitreal carboplatin and etoposide phosphate for retinoblastomaMohney BG, Elner V, Smith AB, Harbour JW, Smith BD, Smith SJ, Ophthalmic Surg Lasers Imaging Retina, 1/1/2017
- Ocular side effects following intravitreal injection therapy for retinoblastoma: A systematic reviewSmith SJ, Smith BD, Mohney BG, Br J Ophthalmol, 1/1/2014
- Quantifying diplopia with a questionnaireHolmes JM, Liebermann L, Hatt SR, Smith SJ, Leske DA, Ophthalmology, 1/1/2013
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Preclinical acute safety study of combined intravitreal carboplatin and etoposide phosphate for retinoblastoma with vitreous seedingSmith SJ, Grossniklaus H, Mruthyunjaya P, Smith BD, Smith AS, Mohney BG, Musch D, The Retina Society Annual Meeting, Paris, France, 2015; Boston, MA, 2017, 1/7/2017
- Ocular Toxicity of Intravitreal Melphalan for RetinoblastomaSmith SJ, Smith BD, Association for Research in Vision and Ophthalmology Annual Meeting, Denver, CO, 1/3/2015
- Maculopathy in patients with monoclonal gammopathy of undetermined significanceSmith SJ, Johnson JM, The Association for Research in Vision and Ophthalmology Annual Meeting, Ft. Lauderdale, FL, 1/8/2014
- Join now to see all
Lectures
- Retinal Vein Occlusion: Basic principles and new clinical insightsPalo Alto, CA - 1/10/2017
- Acute pre-clinical ocular safety study of combined intravitreal carboplatin and etoposide phosphate for retinoblastomaMackinac Island, MI - 1/8/2015
- Fine Needle Aspiration Biopsy (FNAB) for Retinoblastoma: Indications and ContraindicationsOrlando, FL - 1/3/2014
- Join now to see all
Other
- Diabetic retinopathy: halting and reversing progression. The second of three partsSmith SJ, Greven MA, Mruthyunjaya P, Retinal Physician
1/1/2017 - Halting and reversing DR progression with anti-VEGF: clinical and economic relevance. The third of a three-part seriesSmith SJ, Greven MA, Mruthyunjaya P, Retinal Physician
1/1/2017 - Current concepts in diagnosis and management of central retinal artery occlusionGreven MA, Smith SJ, Retinal Physician
1/1/2016 - Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: